The ‘green whistle’: A novel method of analgesia for transrectal prostate biopsy

Jeremy Grummet, Sean Huang, Alex Konstantatos, Mark Frydenberg

British Journal of Urology · 2012 · 17 citations · 27 references

DOIFull text

Open access

Concepts

Abstract

Abstract What's known on the subject? and What does the study add? Periprostatic infiltration of local anaesthetic (PILA) is accepted as the current ‘gold standard’ of analgesia for TRUS‐guided biopsy. However, it does not account for discomfort of anal probe insertion and has not received wide uptake amongst clinicians. A better method is therefore sought. Penthrox TM (methoxyflurane) is an effective systemic analgesic that is self‐administered via a hand‐held inhaler. Its use in TRUS‐guided biopsy has not been previously reported. An initial experience with a novel analgesic for TRUS‐guided biopsy, which appears to be safe and effective. It has led to the planning of a randomised control trial, which will compare Penthrox with PILA for TRUS‐guided biopsy. Objectives To determine the feasibility of using a novel inhaled analgesic agent ( P enthrox TM , methoxyflurane)) for transrectal ultrasonography ( TRUS )‐guided biopsies of the prostate. Patients and methods Patients undergoing TRUS ‐guided biopsies were each given a Penthrox inhaler to self‐administer during the procedure and instructed in its use. Immediately after the procedure, patients were asked to rate their pain using a verbal rating scale from 0 to 10. Results In all, 42 consecutive men underwent a TRUS ‐guided biopsy. The median pain score was 3. All 42 patients stated they would be happy to undergo the same procedure again. The only adverse effects reported by patients were brief light‐headedness and a sickly sweet taste. Conclusion This study of our initial experience using Penthrox suggests that it may have a role in analgesia for TRUS ‐guided biopsy. It may provide safe, adequate analgesia that is easy for urologists to use and avoids excessive use of resources. Planning for a randomised control trial comparing P enthrox to the current ‘gold standard’ of prostatic infiltration of local anaesthetic is presently underway.

References

27